TAMPA, FL / ACCESS Newswire / September 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the pricing of a public offering of 7,142,862 shares of common stock, together with warrants to purchase up to 7,142,862 shares of common stock at a combined public offering price of $0.70 per share and associated warrant. The warrants will have an exercise price of $0.70 per share, wi ...

Not for distribution to U.S. news wire services or dissemination in the United States. VANCOUVER, British Columbia, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Outcrop Silver & Gold Corporation (TSXV:OCG, OTCQX:OCGSF, DE:MRG) (“Outcrop Silver” or the “Company”) is pleased to announce that it has entered into an agreement with BMO Capital Markets, as sole bookrunner, and Research Capital Corporation, as co-lead agent, on behalf of a syndicate of agents (collectively, the “Agents”), in connection with a best efforts, ...

REDWOOD CITY, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a clinical-stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and asthma, announced today the pricing of its underwritten public offering of (i) an aggregate of 11,670,707 shares of its common stock and accompanying commo ...

CUPERTINO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced the pricing of its previously announced public offering with existing and new healthcare focused institutional investors for the purchase and sale of 27,000,000 shares of it ...

NEW YORK--(BUSINESS WIRE)--Rithm Capital Corp. (NYSE: RITM; "Rithm†or the "Company†) announces that it has launched an opportunistic underwritten public offering of Series E Fixed-Rate Cumulative Redeemable Preferred Stock (the "Preferred Stock†), subject to market conditions. The terms of the Preferred Stock are to be determined by negotiations between the Company and the underwriters. The Company intends to apply to list the Preferred Stock on the New York Stock Exchange under the symbol "RI. ...

SAN JUAN, Puerto Rico, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or “Company”), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, announced today the pricing of an underwritten public offering of 15,625,000 shares of common stock at a price to the public of $9.60 per share. The gross proceeds from the offering to the Company are expected to be approximately $150 million, before deducting underwr ...

公司融资活动 - AIRO集团控股公司完成增发483万股普通股 包括承销商全额行使630,000股超额配售权[1] - 本次公开发行获得总收益未披露具体金额 扣除费用前数据未完整呈现[1] - 股票发行于2025年9月12日完成 发行规模较原计划有所扩大[1] 公司业务领域 - 公司专注于先进航空航天与国防技术领域 在纳斯达克交易所上市交易代码为AIRO[1] - 业务覆盖美国新墨西哥州阿尔伯克基 加拿大蒙特利尔 丹麦斯图林等多个地区[1]

公司融资活动 - Nebius Group NV作为领先AI基础设施公司宣布定价承销公开发行10亿美元A类普通股 每股发行价格92.50美元[1] - 公司授予承销商30天超额配售权 可额外购买最多1.5亿美元A类普通股[1]

公司融资活动 - AIRO集团控股公司宣布完成规模扩大的承销公开发行 定价为每股18.50美元[1] - 本次发行普通股数量为420万股 预计总收益约7770万美元（未扣除承销折扣及佣金）[1] - 公司专注于先进航空航天与国防技术领域[1]

公司融资活动 - Veritone公司宣布进行承销公开发行 以每股2[1]63美元的价格出售9,505,705股普通股[1] - 本次发行预计总收益约为2500万美元 需扣除承销折扣和佣金及其他预估费用[1]